Clinical Trials Directory

Trials / Completed

CompletedNCT06384703

The Relationship Between Microbiota and Coronary Ectasia

The Evaluation of the Relationship Between Coronary Ectasia And Trimethylamine N Oxide

Status
Completed
Phase
Study type
Observational
Enrollment
2 (actual)
Sponsor
Konya Beyhekim Training and Research Hospital · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Introduction: It is now known that the microbiota is far beyond the microbial communities living in certain parts of our body and functions like a metabolic organ. In addition, the microbiota, through its metabolites, is involved in the pathophysiology or progression of a wide range of diseases, from atherosclerotic diseases to metabolic diseases and even neurological diseases. Among these metabolites, trimethylamine n-oxide metabolite has been shown to be particularly effective on atherosclerotic heart diseases.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTTaking blood for kit studyTaking blood for kit study (Elisa kit)

Timeline

Start date
2020-11-03
Primary completion
2021-04-25
Completion
2021-06-18
First posted
2024-04-25
Last updated
2024-04-25

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06384703. Inclusion in this directory is not an endorsement.

The Relationship Between Microbiota and Coronary Ectasia (NCT06384703) · Clinical Trials Directory